ZNF252P and ovarian carcinoma: EdU assay revealed that the cell adequacy of ovarian cancer cells was significantly enhanced by miR-324-3p inhibitor, however, the viability of cells was dramatically reduced when the cells were co-transfected with sh-ZNF252P-AS1 and miR-324-5p (Fig. 5C).